Your browser is no longer supported. Please, upgrade your browser.
NVO Novo Nordisk A/S daily Stock Chart
Novo Nordisk A/S
Index- P/E16.29 EPS (ttm)2.11 Insider Own26.40% Shs Outstand1.99B Perf Week5.78%
Market Cap68.55B Forward P/E15.26 EPS next Y2.26 Insider Trans0.00% Shs Float1.26B Perf Month-0.89%
Income5.37B PEG1.85 EPS next Q0.50 Inst Own9.70% Short Float0.25% Perf Quarter-25.17%
Sales15.92B P/S4.31 EPS this Y34.30% Inst Trans-2.37% Short Ratio0.71 Perf Half Y-39.37%
Book/sh2.34 P/B14.71 EPS next Y3.77% ROA42.90% Target Price35.10 Perf Year-37.99%
Cash/sh1.19 P/C28.85 EPS next 5Y8.80% ROE89.20% 52W Range30.89 - 57.43 Perf YTD-39.11%
Dividend1.41 P/FCF32.39 EPS past 5Y22.40% ROI85.00% 52W High-40.06% Beta0.81
Dividend %4.10% Quick Ratio0.90 Sales past 5Y12.20% Gross Margin84.80% 52W Low11.43% ATR0.79
Employees42605 Current Ratio1.20 Sales Q/Q2.80% Oper. Margin43.50% RSI (14)50.08 Volatility1.10% 1.46%
OptionableYes Debt/Eq0.01 EPS Q/Q18.80% Profit Margin33.70% Rel Volume1.26 Prev Close33.93
ShortableYes LT Debt/Eq0.00 EarningsOct 28 BMO Payout43.30% Avg Volume4.38M Price34.42
Recom4.00 SMA203.86% SMA50-7.98% SMA200-29.28% Volume5,539,564 Change1.44%
Oct-31-16Downgrade DNB Markets Buy → Hold
Oct-31-16Downgrade Citigroup Buy → Neutral
Oct-28-16Downgrade BofA/Merrill Neutral → Underperform
Sep-23-16Initiated Piper Jaffray Neutral
Sep-13-16Upgrade Exane BNP Paribas Neutral → Outperform
Sep-09-16Downgrade JP Morgan Overweight → Neutral
Sep-01-16Downgrade Morgan Stanley Overweight → Equal-Weight
Aug-31-16Upgrade HSBC Securities Reduce → Hold
Aug-08-16Downgrade BofA/Merrill Buy → Neutral
Aug-28-15Initiated Leerink Partners Mkt Perform $56
Jun-09-15Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-15-15Initiated Societe Generale Sell
May-28-13Upgrade Deutsche Bank Sell → Hold
Mar-31-10Initiated Deutsche Bank Hold
Mar-30-10Downgrade Mehta Partners Outperform → Market Perform
Feb-24-10Upgrade Jefferies & Co Hold → Buy
Jan-15-10Downgrade Jefferies & Co Buy → Hold
Sep-11-09Initiated Jefferies & Co Buy
Aug-07-09Downgrade UBS Buy → Neutral
Aug-07-09Downgrade JP Morgan Overweight → Neutral
Dec-05-16 05:55PM  A second major drugmaker just committed to limiting price increases
02:38PM  Novo's Pricing Pledge Is a Sign of More to Come at Bloomberg
09:42AM  Novo Nordisk Files for Regulatory Approval of Once-Weekly Semaglutide with the FDA for the Treatment of Type 2 Diabetes PR Newswire
02:30AM  Novo Nordisk A/S (ADR) (NVO)Hedge Funds Are Snapping Up at Insider Monkey
Dec-01-16 04:50PM  These drug and medical device companies made $5.6 million in nonresearch payments to Washington hospitals last year at
Nov-30-16 11:21AM  [$$] Novo Nordisk shares rally on insulin trial results at Financial Times
10:49AM  3 High-Yield Dividend Stocks to Buy in December at Motley Fool
10:04AM  Novo Nordisk's Tresiba Shows Safe Cardiovascular Profile
Nov-29-16 07:22PM  Novo's New Insulin Reduces Risk of Low Blood Sugar, Study Shows at The Wall Street Journal
02:13PM  Novo Nordisk reports Tresiba insulin achieves target in study Reuters
Nov-28-16 09:49AM  New Strong Sell Stocks for November 28th
Nov-25-16 06:09PM  Do Hedge Funds Love Cisco Systems, Inc. (CSCO)? at Insider Monkey
01:14PM  Gurus Invest in Undervalued Biotech Stocks
12:43PM  [$$] Novo Nordisk: shot in the dark at Financial Times
Nov-23-16 11:03AM  US FDA Approves Sanofi SA (ADR) (SNY) Soliqua 100/33, Novo Nordisk A/S (ADR) (NVO) Xultophy 100/3.6 at Insider Monkey
09:13AM  Novo Nordisk's Diabetes Combination Drug Gets FDA's Nod
Nov-22-16 04:04PM  AstraZeneca, Novartis Drop into Tuesdays 52-Week Low Club
02:50PM  FDA Approves Novo Nordisk Diabetes Drug (NVO) at Investopedia
02:16PM  Dueling Diabetes Duos Won't End Price Pressure at Bloomberg
Nov-21-16 04:04PM  Pilgrims Pride, Sunoco Slide into Mondays 52-Week Low Club
11:21AM  23 Questions With Thomas Macpherson of Nintai Partners
Nov-18-16 04:04PM  Infosys, Nielsen Dip into Fridays 52-Week Low Club
Nov-16-16 07:07AM  [$$] US casts shadow on Novo Nordisk ahead of 'perfect storm' at Financial Times
Nov-14-16 09:19AM  5 Pharma Stocks in Focus on World Diabetes Day
08:05AM  One World Trade Center to Glow Blue in Honor of World Diabetes Day Tonight PR Newswire
Nov-11-16 08:39AM  Why Novo Nordisk A/S Stock Dropped 13.6% in October at Motley Fool
Nov-10-16 12:58PM  MannKind Is Still Too Heavy to Avoid the Afrezza Crash Landing
09:30AM  The Zacks Analyst Blog Highlights: Chevron, Glaxo, Aflac, Novo Nordisk and MGM Resorts
02:37AM  Pharma stocks propel European stocks higher after Trump win shakes markets at MarketWatch
Nov-07-16 04:04PM  Concordia, Vodafone in Mondays 52-Week Low Club at 24/7 Wall St.
03:35PM  World Leader in Diabetes Medication Hits 2-Year Low
11:56AM  Buy Health Care Now? It All Depends on the Election
Nov-05-16 11:01AM  Bernie Sanders Seeks DOJ Drug Probe (LLY, SNY) at Investopedia
Nov-04-16 08:04AM  What Do Analysts Recommend for Novo?
Nov-03-16 11:09AM  Roche's Haemophilia Drug Difficulties Has Rivals Looking for an Edge
11:04AM  How Did Novos Biopharmaceuticals Segment Perform in 3Q16?
10:04AM  How Tresiba Helps Novo Achieve Its Growth Targets
08:04AM  Victoza Dominates Global GLP-1 Class
01:00AM  Novo Braces for Threat From Roche on Blood Disorder Drugs at Bloomberg
Nov-02-16 11:04AM  Reading Novos Insulin Portfolio to Find Clues about Its Growth
10:05AM  Novos Dominance in Global Diabetes Market
08:06AM  How Much Did Novo Get from International Regions in 3Q16?
08:00AM  10 Most Successful Investors in the World at Insider Monkey
Nov-01-16 06:04PM  US Still the Largest Market for Novo Nordisk
05:04PM  Analyzing Novos Revenue Growth in 3Q16
04:26PM  Novo Nordisk A/S Plans to Innovate and Diversify to Avoid Payer Pressure at Motley Fool
03:20PM  Bernie Sanders is going after insulin makers over price hikes
02:57PM  Honing in on Novos 3Q16 Revenue and Earnings
02:47PM  Drug Makers Stocks Under Scanner -- Pernix Therapeutics, Novo Nordisk, Synergy Pharma, and Apricus Biosciences PR Newswire
01:17PM  Sanders Takes Aim at Insulin Makers in Latest Price Attack at Bloomberg
12:30PM  Novo Nordisk A/S (ADR) (NVO) Revisits New Strategy To Deal With U.S Payers at Insider Monkey
Oct-31-16 12:46PM  Top Performing CEOs in the World and What Top Performing Hedge Funds Think of Their Companies at Insider Monkey
11:38AM  Novo Nordisk (NVO) Tops Q3 Earnings, Revenues Up Y/Y
09:48AM  Novo Nordisk A/S downgraded by DNB Markets and Citigroup
Oct-30-16 07:00AM  Novo Nordisks Share Implosion Sends Shock Waves Through Denmark
Oct-28-16 04:06PM  Why Novo Nordisk A/S Got Crushed Today at Motley Fool -12.90%
12:30PM  European stocks close lower as Anheuser-Busch cuts view, French data disappoint at MarketWatch
12:29PM  European Stocks Mixed on Divergence in Economic Data, Mixed Earnings
11:40AM  Diabetes Strategies the Difference for Novo, Sanofi at Bloomberg
11:01AM  One of the world's largest insulin makers is getting clobbered after issuing a warning about its prospects
09:28AM  Stocks to Watch: Baker Hughes, Goodyear, Novo Nordisk at The Wall Street Journal
08:35AM  [$$] Novo Nordisk's shares plunge after it slashes profit target at Financial Times
07:18AM  Sanofi, Novo Nordisk Fortunes Diverge Amid Insulin Price Slump at The Wall Street Journal
06:37AM  Novo Nordisk will stay in U.S. insulin market "whatever it costs" - CEO
06:31AM  Novo Nordisk Slashes Long-Term Profit Growth on Pricing at Bloomberg
05:11AM  Novo Nordisk Remains Focused on Diabetes Care: Brandgaard
05:11AM  Novo Nordisk Remains Focused on Diabetes Care: Brandgaard at Bloomberg
05:03AM  Novo Nordisk beats 3Q profit forecasts
04:40AM  Investors Sanguine on Sanofi Post Guidance
04:38AM  Novo Nordisk Stock Plunges as U.S. Problems Cloud Outlook
04:23AM  Novo Nordisk takes beating after slashing full-year growth
04:01AM  [$$] Novo Nordisk Shares Dive on Lower Forecast at The Wall Street Journal
03:43AM  European shares slip as earnings disappointments bite, Novo slides
01:39AM  Novo Plunges After Slashing Long-Term Growth Profit Target at Bloomberg
Oct-25-16 02:04PM  Will Novo See a Drag on Its Margins in 3Q16?
01:04PM  NOVO NORDISK A S Financials
01:04PM  How Much Revenue Growth Could Novo Record in 3Q16?
10:52AM  How Much Is the Return Opportunity for Novo Nordisk in 3Q16?
Oct-24-16 07:04PM  This Company and This Sector Has Hurt the Harbor Capital Appreciation Fund in 2016
Oct-22-16 08:00AM  5 Most Successful Quant Hedge Funds And Their Top Picks at Insider Monkey
Oct-20-16 11:06AM  Novo Nordisk A/S : NVO-US: Dividend Analysis : August 15th, 2016 (record date) : By the numbers : October 20, 2016
Oct-19-16 10:06AM  Eli Lilly and Co.s 3Q16 Estimates: Endocrine Franchise
Oct-17-16 07:49AM  Get Paid While You Wait: 3 Top Dividend Stocks in Big Pharma at Motley Fool
Oct-13-16 08:07AM  3 Attractive Income Stocks Whose Dividends Could Double at Motley Fool
08:06AM  Which Healthcare Company Is the Best Dividend Stock? at Motley Fool
Oct-12-16 10:58AM  Two Dividend Growth Stocks on My Radar at Insider Monkey
Oct-11-16 09:30AM  The Zacks Analyst Blog Highlights: Alphabet, Novo Nordisk, Enterprise Products Partners, Textron and Xerox
Oct-10-16 04:04PM  Bristol-Myers, Staples Fall Into Mondays 52-Week Low Club at 24/7 Wall St.
01:57PM  Top Research Reports for Alphabet, Novo Nordisk & Enterprise Products
01:00PM  4 Blue Chip Stocks For Global Investors at Forbes
Oct-09-16 06:58AM  Why Novo Nordisk Stock Fell 10.2% in September at Motley Fool
Oct-07-16 07:26PM  3 Beaten-Up Big Pharma Stocks: Are They Bargains Now? at Motley Fool
Oct-06-16 11:34AM  Novo Nordisk Is Being Ignored
Oct-05-16 10:32AM  ETFs with exposure to Novo Nordisk A/S : October 5, 2016
Oct-04-16 08:04AM  Will Novo Nordisks Core Capabilities Be Enough to Differentiate Its Research Pipeline?
Oct-03-16 12:09PM  Novo Nordisk (NVO) Stock Drops, Explores Inventing New Forms of Insulin
11:05AM  What Will Drive Novo Nordisks Growth in Diabetes and Hemophilia?
10:06AM  Diabetes Care Market Is Expected to See Fast Growth
10:04AM  Novo Nordisk Expects to Witness Strong Growth from New Product Launches
08:06AM  Volume Growth and Product Mix to Drive NVOs Insulin Sales
Novo Nordisk A/S, a healthcare company, engages in the discovery, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity Care, and Biopharmaceuticals. The Diabetes and Obesity Care segment provides insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia care, growth hormone therapy, and hormone replacement therapy. The company markets and distributes its products through distributors and independent agents in North America, Europe, Japan and South Korea, China, Hong Kong, Taiwan, and other countries. Novo Nordisk A/S has a collaboration agreement with the Langer Laboratory. The company was founded in 1925 and is headquartered in Bagsvaerd, Denmark.